KMT2A and acute myeloid leukemia: In line with previous reports, we found the highest MYB expression in AML characterized by MLL fusions and RUNX1-ETO translocation as compared with healthy bone marrow donors, whereas no differences were observed in patients with Inv [16] lesions and abnormal/complex karyotype (Figure S1A).